Literature DB >> 8140213

Malaria prophylaxis: identifying risk groups for non-compliance.

T K Held1, T Weinke, U Mansmann, M Trautmann, H D Pohle.   

Abstract

To investigate behaviour in the use of drug prophylaxis against malaria and the risk factors for non-compliance, 507 European or North American travelers returning from endemic areas were studied retrospectively at Berlin in a 11-year period from 1980 to 1990. Compliance was significantly correlated with shorter travel duration: the group with good compliance stayed 37.2 +/- 38.5 days (mean +/- SD) in contrast to 69.8 +/- 93.5 days in the group of patients with no compliance (p = 0.00001). Older patients were significantly more compliant than patients aged < 55 years (20/27 compliant at > 54 years vs. 175/476 at < 55 years; p = 0.0001). Compliance was significantly affected by travel destination (Southern and East African regions; p = 0.0054), age (< or = 15 and > or = 55 years, respectively; p = 0.0001), and reason of travel (package tours; p = 0.0001). CART analysis confirmed logistic regression analysis with respect to age and travel type, and revealed that patients using only one information source were significantly more compliant than those using two or more information sources. Travel agencies were nearly as well informed as Institutes of Tropical Medicine, but family doctors had a significant incidence of giving wrong advice. This study should enable medical personnel dealing with prophylactic advice against malaria to identify patients at high risk for non-compliance, and to educate them more carefully than other travellers regarding antimalarial drug prophylaxis.

Entities:  

Mesh:

Year:  1994        PMID: 8140213

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  6 in total

Review 1.  Antimalarial chemoprophylaxis in infants and children.

Authors:  M H Kramer; H O Lobel
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  [Travelling immigrants].

Authors:  L Valerio; L Guerrero; O Martínez; M Sabrià; P Garrido; A Fabregat; M D Reina
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

3.  Survey of use of malaria prevention measures by Canadians visiting India.

Authors:  C C dos Santos; A Anvar; J S Keystone; K C Kain
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

Review 4.  WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers.

Authors:  A M J Croft; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

5.  Ranking malaria risk factors to guide malaria control efforts in African highlands.

Authors:  Natacha Protopopoff; Wim Van Bortel; Niko Speybroeck; Jean-Pierre Van Geertruyden; Dismas Baza; Umberto D'Alessandro; Marc Coosemans
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

6.  Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.